Division of Head and Neck Surgery, Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong.
Laryngoscope. 2012 Aug;122(8):1779-81. doi: 10.1002/lary.23380. Epub 2012 Jul 2.
OBJECTIVES/HYPOTHESIS: It is not uncommon for head and neck surgeons to encounter patients with previous neck irradiation that require fine-needle aspiration cytology (FNAC) for assessment of neck mass. It had been observed that the diagnostic performance of FNAC appears to be poorer among patients with previous irradiation. However, to the best of our knowledge, the effect of previous irradiation on diagnostic performance of FNAC has never been studied.
Retrospective study.
A computer search was performed to identify all patients who had been treated under the Division of Head and Neck Surgery, Department of Surgery, Queen Mary Hospital, from January 2008 to December 2010. We retrospectively retrieved all FNAC of cervical lymphadenopathy procedures, and only cases with subsequent histologic confirmation were included. All patients with squamous cell carcinoma of the head and neck (HNSCC) were included.
When compared to patients without previous irradiation, FNAC among patients with history of previous irradiation had comparable specificity (100% vs. 88%) and positive predictive value (100% vs. 89%) but significantly worse sensitivity (82% vs. 40%), negative predictive value (74% vs. 37%), and accuracy (88% vs. 54%). History of previous irradiation was found to be strongly associated with false-negative cytologic results among those with positive final histology (60% vs. 18%; P = .001).
FNAC remains an important diagnostic tool in assessment of cervical nodal status in HNSCC. However, our study showed that false-negative rate is significantly higher among patients with previous neck irradiation. Negative FNAC results in this group of patients should be interpreted with caution.
目的/假设:头颈部外科医生经常会遇到需要进行细针穿刺细胞学检查(FNAC)来评估颈部肿块的既往颈部放疗患者。据观察,既往接受过放疗的患者的 FNAC 诊断性能似乎较差。然而,据我们所知,既往放疗对 FNAC 诊断性能的影响从未被研究过。
回顾性研究。
通过计算机检索,确定了 2008 年 1 月至 2010 年 12 月在玛丽医院头颈外科接受治疗的所有患者。我们回顾性地检索了所有颈部淋巴结肿大的 FNAC 程序,仅纳入有后续组织学证实的病例。所有头颈部鳞状细胞癌(HNSCC)患者均纳入。
与无既往放疗史的患者相比,既往放疗史患者的 FNAC 具有相当的特异性(100%与 88%)和阳性预测值(100%与 89%),但敏感性显著降低(82%与 40%)、阴性预测值(74%与 37%)和准确性(88%与 54%)。在最终组织学为阳性的患者中,既往放疗史与假阴性细胞学结果密切相关(60%与 18%;P =.001)。
FNAC 仍然是评估 HNSCC 颈部淋巴结状态的重要诊断工具。然而,我们的研究表明,既往颈部放疗患者的假阴性率显著较高。在这组患者中,阴性 FNAC 结果应谨慎解释。